Atrium Therapeutics, Inc. (RNA)
13.04
-0.26
(-1.95%)
USD |
NASDAQ |
May 14, 11:12
Atrium Therapeutics Market Cap : 202.32M for May 14, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| KalVista Pharmaceuticals, Inc. | 1.424B |
| Intellia Therapeutics, Inc. | 1.879B |
| Recursion Pharmaceuticals, Inc. | 1.661B |
| Tango Therapeutics, Inc. | 3.322B |
| ACADIA Pharmaceuticals, Inc. | 3.800B |
Market Cap Related Metrics
| Price | 13.04 |
| Earnings Yield | -18.21% |